WASHINGTON TRUST Co raised its stake in shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 3.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 83,840 shares of the pharmacy operator’s stock after buying an additional 2,422 shares during the period. WASHINGTON TRUST Co’s holdings in Walgreens Boots Alliance were worth $6,759,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Thomaspartners Inc. increased its stake in shares of Walgreens Boots Alliance by 0.4% in the second quarter. Thomaspartners Inc. now owns 4,337 shares of the pharmacy operator’s stock valued at $361,000 after buying an additional 18 shares in the last quarter. Alpha Windward LLC increased its stake in shares of Walgreens Boots Alliance by 0.6% in the third quarter. Alpha Windward LLC now owns 3,227 shares of the pharmacy operator’s stock valued at $260,000 after buying an additional 18 shares in the last quarter. First Citizens Bank & Trust Co. increased its stake in shares of Walgreens Boots Alliance by 0.9% in the second quarter. First Citizens Bank & Trust Co. now owns 2,470 shares of the pharmacy operator’s stock valued at $206,000 after buying an additional 21 shares in the last quarter. Blue Chip Partners Inc. increased its stake in shares of Walgreens Boots Alliance by 0.4% in the second quarter. Blue Chip Partners Inc. now owns 6,633 shares of the pharmacy operator’s stock valued at $552,000 after buying an additional 24 shares in the last quarter. Finally, Cobiz Investment Management LLC increased its stake in shares of Walgreens Boots Alliance by 0.3% in the third quarter. Cobiz Investment Management LLC now owns 7,423 shares of the pharmacy operator’s stock valued at $598,000 after buying an additional 25 shares in the last quarter. 58.93% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded down 0.58% during trading on Wednesday, reaching $85.03. The company’s stock had a trading volume of 4,111,518 shares. The company’s 50-day moving average is $81.44 and its 200-day moving average is $81.10. The stock has a market cap of $92.11 billion, a PE ratio of 22.26 and a beta of 1.19. Walgreens Boots Alliance Inc. has a 12 month low of $71.50 and a 12 month high of $87.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, beating the Zacks’ consensus estimate of $0.99 by $0.08. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. The firm had revenue of $28.60 billion for the quarter, compared to analyst estimates of $29.06 billion. During the same period last year, the firm posted $0.88 earnings per share. The business’s revenue for the quarter was up .4% on a year-over-year basis. Equities analysts expect that Walgreens Boots Alliance Inc. will post $5.01 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 17th will be paid a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date of this dividend is Tuesday, November 15th. Walgreens Boots Alliance’s payout ratio is 39.27%.

ILLEGAL ACTIVITY NOTICE: “WASHINGTON TRUST Co Has $6,759,000 Position in Walgreens Boots Alliance Inc. (WBA)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2016/11/30/washington-trust-co-has-6759000-position-in-walgreens-boots-alliance-inc-wba.html.

Several brokerages recently issued reports on WBA. Deutsche Bank AG reiterated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Friday, September 9th. Robert W. Baird reissued an “outperform” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Saturday, September 10th. Barclays PLC set a $79.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Friday, October 21st. Jefferies Group set a $95.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Sunday, October 23rd. Finally, Leerink Swann reissued an “outperform” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, September 19th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and an average target price of $90.30.

In related news, EVP Kathleen Wilson-Thompson sold 23,996 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $85.00, for a total value of $2,039,660.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Stefano Pessina acquired 2,000,000 shares of the business’s stock in a transaction that occurred on Friday, November 4th. The stock was bought at an average cost of $81.41 per share, for a total transaction of $162,820,000.00. The disclosure for this purchase can be found here. Insiders own 21.10% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.